Novel Combination Therapy Enhances Control of Advanced Prostate Cancer#United_States#Chicago#MEDSIR#Prostate_Cancer#ZZ-FIRST_study
Novel Combination Therapy Enhances Control of Advanced Prostate Cancer
MEDSIR reveals promising results from the ZZ-FIRST study, showing that combined therapy improves disease management in hormone-sensitive prostate cancer.
third-news.com
June 1, 2026 at 10:08 AM
Novel Combination Therapy Enhances Control of Advanced Prostate Cancer#United_States#Chicago#MEDSIR#Prostate_Cancer#ZZ-FIRST_study